Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Protoporphyria, Erythropoietic

• INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP
• Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP
• Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP
• Effect of Oral Cimetidine in the Protoporphyrias
• Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
• A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)
• Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoetic Protoporphyria or X-Linked Protoporphyria
• Multicentre Phase III Erythropoietic Protoporphyria Study
• Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria
• Oral Iron for Erythropoietic Protoporphyrias
• Phase III Confirmatory Study in Erythropoietic Protoporphyria
• Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria
• Sorbent Therapy of the Cutaneous Porphyrias
• Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)
• Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)
• Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
• Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria